In the BioHarmony Drug Report Database

"Preview" Icon

Fludarabine

Fludara, Fludarabine Phosphate, Oforta (fludarabine phosphate) is a small molecule pharmaceutical. Fludarabine phosphate was first approved as Fludara on 1991-04-18. It is used to treat b-cell chronic lymphocytic leukemia and non-hodgkin lymphoma in the USA. Fludarabine’s patent is valid until 2022-12-20 (FDA).

 

Trade Name

 

Fludara, Fludarabine Phosphate, Oforta
 

Common Name

 

fludarabine phosphate
 

ChEMBL ID

 

CHEMBL1096882
 

Indication

 

b-cell chronic lymphocytic leukemia, non-hodgkin lymphoma
 

Drug Class

 

Antineoplastics (arabinofuranosyl derivatives)

Image (chem structure or protein)

Fludarabine structure rendering